Impact of occluder device configurations in in-silico left atrial hemodynamics for the analysis of device-related thrombus
Carlos Albors,Jordi Mill,Andy L. Olivares,Xavier Iriart,Hubert Cochet,Oscar Camara
DOI: https://doi.org/10.1371/journal.pcbi.1011546
2024-09-28
PLoS Computational Biology
Abstract:Left atrial appendage occlusion devices (LAAO) are a feasible alternative for non-valvular atrial fibrillation (AF) patients at high risk of thromboembolic stroke and contraindication to antithrombotic therapies. However, optimal LAAO device configurations (i.e., size, type, location) remain unstandardized due to the large anatomical variability of the left atrial appendage (LAA) morphology, leading to a 4-6% incidence of device-related thrombus (DRT). In-silico simulations have the potential to assess DRT risk and identify the key factors, such as suboptimal device positioning. This work presents fluid simulation results computed on 20 patient-specific left atrial geometries, analysing different commercially available LAAO occluders, including plug-type and pacifier-type devices. In addition, we explored two distinct device positions: 1) the real post-LAAO intervention configuration derived from follow-up imaging; and 2) one covering the pulmonary ridge if it was not achieved during the implantation (13 out of 20). In total, 33 different configurations were analysed. In-silico indices indicating high risk of DRT (e.g., low blood flow velocities and flow complexity around the device) were combined with particle deposition analysis based on a discrete phase model. The obtained results revealed that covering the pulmonary ridge with the LAAO device may be one of the key factors to prevent DRT, resulting in higher velocities and reduced flow recirculations (e.g., mean velocities of 0.183 ± 0.12 m/s and 0.236 ± 0.16 m/s for uncovered versus covered positions in DRT patients). Moreover, disk-based devices exhibited enhanced adaptability to various LAA morphologies and, generally, demonstrated a lower risk of abnormal events after LAAO implantation. Atrial fibrillation, a condition characterized by an irregular heart rhythm, is closely linked to the risk of stroke and, subsequently, human deaths. Due to the high rate of drug contraindications among patients with atrial fibrillation and the growing number of people affected by this condition, it is crucial to find new or more appropriate treatments. One such alternative is the left atrial appendage closure (LAAO) procedure, which involves placing a device to seal off a small cavity in the heart called the left atrial appendage (LAA). This area is known to be a common site for thrombus formation. However, the success of this therapy depends significantly on the anatomical variability of the LAA, the choice of the device among those available on the market, and the clinical expertise involved, as improper placement can increase the risk of thrombus formation. To address these challenges, we have developed a computational pipeline and tested it using data from 20 real patients' hearts. Our study examines how blood flow varies with different devices and placements within the LAA. Our findings provide useful insights to avoid sub-optimal device positioning, which can help clinicians reduce the risk of thrombus formation following the LAAO procedure.
biochemical research methods,mathematical & computational biology